Orbis Investment Management (US)’s Elevance Health ELV Stock Holding History

Orbis Investment Management (US)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-33,455	Closed	-$6.35M	–	24
2017 Q3	$6.35M	Sell	33,455 -23,477	-41%	-$4.47M	3.95%	14
2017 Q2	$10.7M	Sell	56,932 -2,400	-4%	-$431K	7.07%	3
2017 Q1	$9.81M	Sell	59,332 -16,306	-22%	-$2.59M	6.84%	4
2016 Q4	$10.9M	Buy	75,638 +26,139	+53%	+$3.5M	7.81%	4
2016 Q3	$6.2M	Buy	49,499 +23,225	+88%	+$3M	4.41%	6
2016 Q2	$3.45M	Buy	26,274 +25,189	+2,322%	+$3.45M	2.9%	18
2016 Q1	$151K	Buy	+1,085	New	+$145K	0.13%	22
2014 Q2	–	Sell	-25,102	Closed	-$2.5M	–	32
2014 Q1	$2.5M	Sell	25,102 -7,030	-22%	-$636K	2.27%	21
2013 Q4	$2.97M	Buy	+32,132	New	+$2.86M	2.72%	14

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Orbis Investment Management (US)'s ELV Position: Q4 2017 in Review

Orbis Investment Management (US) sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 33,455 shares — an estimated $6.35M sold.

Orbis Investment Management (US) first reported a position in ELV in Q4 2013 and held it in 9 quarters. The position peaked at $10.9M in Q4 2016. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

Orbis Investment Management (US) reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
Orbis Investment Management (US) sold 33,455 Elevance Health shares in Q4 2017, an estimated $6.35M.
Orbis Investment Management (US) first reported a position in Elevance Health in Q4 2013 and held it in 9 quarters.
Orbis Investment Management (US)'s Elevance Health position peaked at $10.9M in Q4 2016.
909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on Orbis Investment Management (US)'s 13F filing for Q4 2017, filed 14 Feb 2018.